INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 290 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $5,737,000 | +469.1% | 470,987 | +432.2% | 0.01% | +600.0% |
Q4 2018 | $1,008,000 | -72.5% | 88,492 | -47.7% | 0.00% | -50.0% |
Q3 2018 | $3,672,000 | +143.5% | 169,260 | +98.4% | 0.00% | 0.0% |
Q2 2018 | $1,508,000 | -8.4% | 85,328 | +9.2% | 0.00% | 0.0% |
Q1 2018 | $1,646,000 | +45.0% | 78,174 | -0.3% | 0.00% | +100.0% |
Q4 2017 | $1,135,000 | +15.1% | 78,406 | +25.5% | 0.00% | 0.0% |
Q3 2017 | $986,000 | +26.7% | 62,494 | -0.2% | 0.00% | 0.0% |
Q2 2017 | $778,000 | -18.0% | 62,615 | +7.3% | 0.00% | 0.0% |
Q1 2017 | $949,000 | -11.4% | 58,377 | -17.7% | 0.00% | -50.0% |
Q4 2016 | $1,071,000 | -0.3% | 70,948 | +0.6% | 0.00% | 0.0% |
Q3 2016 | $1,074,000 | -62.9% | 70,505 | -5.4% | 0.00% | -60.0% |
Q2 2016 | $2,893,000 | +72.2% | 74,530 | +23.4% | 0.01% | +66.7% |
Q1 2016 | $1,680,000 | -44.7% | 60,415 | +7.0% | 0.00% | -50.0% |
Q4 2015 | $3,038,000 | +58.0% | 56,484 | +17.6% | 0.01% | +50.0% |
Q3 2015 | $1,923,000 | +67.5% | 48,034 | +33.7% | 0.00% | +100.0% |
Q2 2015 | $1,148,000 | +99.7% | 35,925 | +49.2% | 0.00% | +100.0% |
Q1 2015 | $575,000 | +35.3% | 24,080 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $425,000 | +28.8% | 24,080 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $330,000 | -18.7% | 24,080 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $406,000 | – | 24,080 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |